Cancer Therapy News and Research

RSS

New technique could improve selectivity of cancer drugs, decrease unwanted side effects in future

A class of therapeutic drugs known as protein kinase inhibitors has in the past decade become a powerful weapon in the fight against various life-threatening diseases, including certain types of leukemia, lung cancer, kidney cancer and squamous cell cancer of the head and neck.

11 Sep 2015

Inhibition of Tyk2 enzyme promotes anti-cancer activity

Tyrosine kinase 2 (Tyk2) is an enzyme involved in intracellular signalling and has an important role in activating the immune system.

11 Sep 2015

Johns Hopkins Kimmel Cancer Center to break ground on new cancer care building in East Baltimore

The Johns Hopkins Kimmel Cancer Center will break ground Sept. 10 on a new $100 million, 184,000-square-foot cancer care building at one of the highest elevations in East Baltimore.

11 Sep 2015

Researchers discover new strategy for attacking cancer cells

University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease.

11 Sep 2015

UVA researchers identify new strategy for attacking cancer cells

University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By more selectively targeting cancer cells, this method offers a strategy to reduce the length of and physical toll associated with current treatments.

10 Sep 2015

Study finds increased rates of breast cancer incidence, mortality in low and middle income countries

A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.

10 Sep 2015

New statistical model may help predict patients more likely to benefit from surgical treatment for mesothelioma

A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article in the September 2015 issue of the Annals of Thoracic Surgery.

9 Sep 2015

New study examines effect of exercise on outcomes for older breast cancer survivors

Physician-scientists at University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine are leading a new study exploring the impact of exercise on outcomes for older breast cancer survivors.

9 Sep 2015

UCSF researchers lead $10 million research project on pediatric cancer

Researchers at UC San Francisco are leading a five-year, $10 million research project dedicated to pediatric cancer, funded by the first grant of its kind to focus on a molecular pathway that underlies many cancers rather than on a cancer in a particular organ or tissue in the body.

9 Sep 2015

Warwick Medical School to lead study on the effect of physiotherapy after breast cancer surgery

What is expected to be the biggest UK study on the effect of physiotherapy on women after breast cancer surgery is to be led by Warwick Medical School in partnership with University Hospitals Coventry and Warwickshire NHS Trust.

9 Sep 2015

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.

8 Sep 2015

Aspirin may help boost effectiveness of cancer treatment

Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell today (Thursday).

3 Sep 2015

Incorporating clinical genomic sequencing data into clinical management improves pediatric cancer treatment

In a study that included children and young adults with relapsed or refractory cancer, incorporation of integrative clinical genomic sequencing data into clinical management was feasible, revealed potentially actionable findings in nearly half of the patients, and was associated with change in treatment and family genetics counseling for a small proportion of patients, according to a study in the September 1 issue of JAMA.

2 Sep 2015

U-M study suggests potential treatment options for children with aggressive, advanced cancer

For children with rare, aggressive and advanced cancer, precision medicine may help doctors determine their best treatment options, a new study finds.

2 Sep 2015

Health leaders to deliver presentations at Health Connect South 2015

Health Connect South, a non-profit organization serving the health community as a sustainable platform for regional health collaborations, will convene top innovators, decision makers and leaders from throughout the Southeast to speak at its second annual health leadership event on Wednesday, Sept. 16, 2015 at the Georgia Aquarium.

2 Sep 2015

Men with relatively unaggressive prostate tumors unlikely to develop metastatic prostate cancer

Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.

1 Sep 2015

New statistical model may help predict patients most likely to benefits from surgical treatment for mesothelioma

1 Sep 2015

Robotic surgeon offers free consultation for patients diagnosed with prostate cancer

September marks the beginning of Prostate Cancer Awareness Month. World renowned robotic prostate cancer surgeon, Dr. David Samadi, is offering a free phone consultation for patients newly diagnosed with Prostate Cancer.

1 Sep 2015

Northwestern University receives $11.7 million NCI grant to use nanotechnology for cancer treatments

Northwestern University, a leader in cancer nanotechnology research, has received a five-year, $11.7 million grant from the National Cancer Institute to use nanotechnology to develop next-generation cancer treatments.

1 Sep 2015

Bionomics submission of BNC101 IND for cancer treatment passes FDA review

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today announced that its BNC101 IND submission has passed review by the US Food and Drug Administration (FDA).

31 Aug 2015

Cancer Therapy News and Research

New technique could improve selectivity of cancer drugs, decrease unwanted side effects in future

Inhibition of Tyk2 enzyme promotes anti-cancer activity

Johns Hopkins Kimmel Cancer Center to break ground on new cancer care building in East Baltimore

Researchers discover new strategy for attacking cancer cells

UVA researchers identify new strategy for attacking cancer cells

Study finds increased rates of breast cancer incidence, mortality in low and middle income countries

New statistical model may help predict patients more likely to benefit from surgical treatment for mesothelioma

New study examines effect of exercise on outcomes for older breast cancer survivors

UCSF researchers lead $10 million research project on pediatric cancer

Warwick Medical School to lead study on the effect of physiotherapy after breast cancer surgery

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

Aspirin may help boost effectiveness of cancer treatment

Incorporating clinical genomic sequencing data into clinical management improves pediatric cancer treatment

U-M study suggests potential treatment options for children with aggressive, advanced cancer

Health leaders to deliver presentations at Health Connect South 2015

Men with relatively unaggressive prostate tumors unlikely to develop metastatic prostate cancer

New statistical model may help predict patients most likely to benefits from surgical treatment for mesothelioma

Robotic surgeon offers free consultation for patients diagnosed with prostate cancer

Northwestern University receives $11.7 million NCI grant to use nanotechnology for cancer treatments

Bionomics submission of BNC101 IND for cancer treatment passes FDA review

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News